Cargando…
Recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-Arginine
PURPOSE: To report a case of a healthy, young male with recurrent herpes zoster ophthalmicus (HZO) and high-dose l-arginine supplementation. OBSERVATIONS: A 39-year-old man presented to another institution with a HZO involving the right eye. He was treated with oral acyclovir with complete resolutio...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722283/ https://www.ncbi.nlm.nih.gov/pubmed/31497676 http://dx.doi.org/10.1016/j.ajoc.2019.100547 |
_version_ | 1783448502890659840 |
---|---|
author | LoBue, Stephen A. Tailor, Prashant Carlson, Stacy M. Mano, Fukutaro Giovane, Richard A. Schaefer, Erin LoBue, Thomas D. |
author_facet | LoBue, Stephen A. Tailor, Prashant Carlson, Stacy M. Mano, Fukutaro Giovane, Richard A. Schaefer, Erin LoBue, Thomas D. |
author_sort | LoBue, Stephen A. |
collection | PubMed |
description | PURPOSE: To report a case of a healthy, young male with recurrent herpes zoster ophthalmicus (HZO) and high-dose l-arginine supplementation. OBSERVATIONS: A 39-year-old man presented to another institution with a HZO involving the right eye. He was treated with oral acyclovir with complete resolution. Four months later the patient had a recurrent HZO episode and was started again on oral acyclovir. After resolution of the episode, the patient was continued on 1 g of oral acyclovir daily as a prophylactic measure. He then presented to our institution for a second opinion. The patient was otherwise healthy, with no past medical history involving systemic immunosuppressant agents or HIV. However, the patient was an active weight lifter taking high doses of amino acids. A diet recall was performed prior to both HZO episodes, which calculated an average intake of 46.5 g of l-arginine a day. Examination revealed 20/40 best-corrected acuity, anterior stromal haze in the visual axis, and inferior superficial punctate keratitis in the right eye. The patient was treated for dry eye disease with punctual plugs and artificial tears. The patient was instructed to decrease all supplemental arginine consumption while continuing with oral acyclovir prophylaxis for one year. CONCLUSIONS AND IMPORTANCE: l-arginine is associated with the replication and virulence of a variety of viruses in vitro, including herpes simplex and varicella zoster. Although arginine consumption increased prior to the initial and recurrent HZO infection, further investigation needs to be performed to deem if a true association exists. |
format | Online Article Text |
id | pubmed-6722283 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-67222832019-09-06 Recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-Arginine LoBue, Stephen A. Tailor, Prashant Carlson, Stacy M. Mano, Fukutaro Giovane, Richard A. Schaefer, Erin LoBue, Thomas D. Am J Ophthalmol Case Rep Case Report PURPOSE: To report a case of a healthy, young male with recurrent herpes zoster ophthalmicus (HZO) and high-dose l-arginine supplementation. OBSERVATIONS: A 39-year-old man presented to another institution with a HZO involving the right eye. He was treated with oral acyclovir with complete resolution. Four months later the patient had a recurrent HZO episode and was started again on oral acyclovir. After resolution of the episode, the patient was continued on 1 g of oral acyclovir daily as a prophylactic measure. He then presented to our institution for a second opinion. The patient was otherwise healthy, with no past medical history involving systemic immunosuppressant agents or HIV. However, the patient was an active weight lifter taking high doses of amino acids. A diet recall was performed prior to both HZO episodes, which calculated an average intake of 46.5 g of l-arginine a day. Examination revealed 20/40 best-corrected acuity, anterior stromal haze in the visual axis, and inferior superficial punctate keratitis in the right eye. The patient was treated for dry eye disease with punctual plugs and artificial tears. The patient was instructed to decrease all supplemental arginine consumption while continuing with oral acyclovir prophylaxis for one year. CONCLUSIONS AND IMPORTANCE: l-arginine is associated with the replication and virulence of a variety of viruses in vitro, including herpes simplex and varicella zoster. Although arginine consumption increased prior to the initial and recurrent HZO infection, further investigation needs to be performed to deem if a true association exists. Elsevier 2019-08-20 /pmc/articles/PMC6722283/ /pubmed/31497676 http://dx.doi.org/10.1016/j.ajoc.2019.100547 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report LoBue, Stephen A. Tailor, Prashant Carlson, Stacy M. Mano, Fukutaro Giovane, Richard A. Schaefer, Erin LoBue, Thomas D. Recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-Arginine |
title | Recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-Arginine |
title_full | Recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-Arginine |
title_fullStr | Recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-Arginine |
title_full_unstemmed | Recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-Arginine |
title_short | Recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-Arginine |
title_sort | recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-arginine |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722283/ https://www.ncbi.nlm.nih.gov/pubmed/31497676 http://dx.doi.org/10.1016/j.ajoc.2019.100547 |
work_keys_str_mv | AT lobuestephena recurrentherpeszosterophthalmicusinayounghealthyindividualtakinghighdosesoflarginine AT tailorprashant recurrentherpeszosterophthalmicusinayounghealthyindividualtakinghighdosesoflarginine AT carlsonstacym recurrentherpeszosterophthalmicusinayounghealthyindividualtakinghighdosesoflarginine AT manofukutaro recurrentherpeszosterophthalmicusinayounghealthyindividualtakinghighdosesoflarginine AT giovanericharda recurrentherpeszosterophthalmicusinayounghealthyindividualtakinghighdosesoflarginine AT schaefererin recurrentherpeszosterophthalmicusinayounghealthyindividualtakinghighdosesoflarginine AT lobuethomasd recurrentherpeszosterophthalmicusinayounghealthyindividualtakinghighdosesoflarginine |